Results 121 to 130 of about 4,355 (175)

Early experience on omaveloxolone in adult patients with Friedreich's ataxia: a real-world observational study. [PDF]

J Neurol
Lima SM, Caltagirone M, Messina C, Quartetti U, Rini N, D'Amico F, Brighina F, Di Stefano V.   +7 more
europepmc   +1 more source

Skeletal muscle transcriptomics dissects the pathogenesis of Friedreich's ataxia. [PDF]

Hum Mol Genet, 2023
Indelicato E, Kirchmair A, Amprosi M, Steixner S, Nachbauer W, Eigentler A, Wahl N, Apostolova G, Krogsdam A, Schneider R, Wanschitz J, Trajanoski Z, Boesch S.   +12 more
europepmc   +1 more source

Development of an AAV-based gene therapy for the ocular phenotype of Friedreich's ataxia. [PDF]

Mol Ther
Tang H, Gupte S, Xu E, Calabro KR, Friend H, Crosson SM, Fajardo D, Kostamo Z, Zhang H, Peterson JJ, Lin F, Kozmik Z, Lutz CM, Boye SL, Boye SE.   +14 more
europepmc   +1 more source

Characterizing Population Pharmacokinetics of Vatiquinone in Healthy Volunteers and Patients with Friedreich's Ataxia. [PDF]

Pharmaceuticals (Basel)
Hu Y, Gao L, Lee L, Cherry JJ, Kong R.
europepmc   +1 more source

Safety and efficacy of individualised exercise and NAD⁺ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial. [PDF]

Lancet Neurol
Lin KY, Bucha A, McSweeney K, Wade KL, Karaj A, Tamaroff J, O'Malley S, Chung NM, Cilenti NA, Wanner J, Adzika GK, Mesaros C, Blair IA, Rojsajjakul T, Serai S, Farmer J, Bryant K, Lu Y, Harhay MO, Weber DR, Paridon SM, Seifert EL, Putt ME, Zamani P, Baur JA, Lynch DR, McCormack SE.   +26 more
europepmc   +1 more source

Pharmacokinetics and Pharmacodynamics of Nomlabofusp in Non-clinical Studies of Friedreich's Ataxia. [PDF]

AAPS J
De Toni F, Ragaglia V, Schecter D, Miller AS, Gonzalez E, Wagner EJ, Xu X, Payne RM, Mess JN, Baile MG, Clements-Egan A, Shankar G.   +11 more
europepmc   +1 more source

Muscle Endurance Training in a Person with Friedreich's Ataxia. [PDF]

Muscles
McGarrell NT, Green ME, McCully KK.
europepmc   +1 more source

Correction: A natural history study to track brain and spinal cord changes in individuals with Friedreich's ataxia: TRACK-FA study protocol. [PDF]

PLoS One
Georgiou-Karistianis N, Corben LA, Reetz K, Adanyeguh IM, Corti M, Deelchand DK, Delatycki MB, Dogan I, Evans R, Farmer J, França MC, Gaetz W, Harding IH, Harris KS, Hersch S, Joules R, Joers JJ, Krishnan ML, Lax M, Lock EF, Lynch D, Mareci T, Gamage SM, Pandolfo M, Papoutsi M, Rezende TJR, Roberts TPL, Rosenberg JT, Romanzetti S, Schulz JB, Schilling T, Schwarz AJ, Subramony S, Yao B, Zicha S, Lenglet C, Henry PG.   +36 more
europepmc   +2 more sources

Editorial: The mechanistic investigation and emerging therapies for Friedreich's ataxia. [PDF]

Front Pharmacol
Dong Y, Chandran V, Soragni E, Lynch DR.
europepmc   +1 more source

Disease Progression in Children With Friedreich Ataxia: Functional Performance and Other Outcome Assessments in the FACHILD Study. [PDF]

J Child Neurol
Rummey C, Perlman S, Subramony SH, Corti M, Farmer J, Lynch DR.   +5 more
europepmc   +1 more source